Literature DB >> 8963448

Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats.

C A Barnes1, W Danysz, C G Parsons.   

Abstract

Chronic treatment of adult male F-344 rats (9-12 months old) with therapeutically relevant doses of memantine (30 mg/kg/day in chow for > 8 weeks) increased the maintenance of long-term potentiation of field excitatory postsynaptic potentials from perforant path-granule cell hippocampal synapses recorded in the fascia dentata in vivo. In contrast, there was no effect of memantine on baseline synaptic responses or population spikes. Likewise, short-term exploratory modulation of these hippocampal evoked responses was not different between memantine-treated and control rats. Both groups of rats were able to learn the spatial version of the Morris water task equally well, but the memantine-treated group showed a strong tendency to show more selective spatial search patterns in the training quadrant of the water pool during a final probe trial. As such, these studies provide the first electrophysiological evidence that memantine can increase the durability of synaptic plasticity and provide preclinical confirmation of the cognitive improvement seen with memantine in the treatment of demented patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8963448     DOI: 10.1111/j.1460-9568.1996.tb01241.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  34 in total

1.  S 18986 reverses spatial working memory impairments in aged mice: comparison with memantine.

Authors:  Matthias Vandesquille; Ali Krazem; Caroline Louis; Pierre Lestage; Daniel Béracochéa
Journal:  Psychopharmacology (Berl)       Date:  2011-01-28       Impact factor: 4.530

2.  Improvement of contextual memory by S 24795 in aged mice: comparison with memantine.

Authors:  Daniel Beracochea; Aurelie Boucard; Caryn Trocme-Thibierge; Philippe Morain
Journal:  Psychopharmacology (Berl)       Date:  2007-11-22       Impact factor: 4.530

3.  Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; T O Aamo; H A Jøorgensen
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Glutamate receptor-mediated restoration of experience-dependent place field expansion plasticity in aged rats.

Authors:  Sara N Burke; Andrew P Maurer; Zhiyong Yang; Zaneta Navratilova; Carol A Barnes
Journal:  Behav Neurosci       Date:  2008-06       Impact factor: 1.912

5.  Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.

Authors:  Jason Lockrow; Heather Boger; Heather Bimonte-Nelson; Ann-Charlotte Granholm
Journal:  Behav Brain Res       Date:  2010-04-02       Impact factor: 3.332

6.  Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.

Authors:  Anders Wimo; Bengt Winblad; Albrecht Stöffler; Yvonne Wirth; Hans-Jörg Möbius
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Authors:  Debby Van Dam; Dorothee Abramowski; Matthias Staufenbiel; Peter Paul De Deyn
Journal:  Psychopharmacology (Berl)       Date:  2005-01-15       Impact factor: 4.530

8.  Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

Review 9.  Anti-dementia drugs and hippocampal-dependent memory in rodents.

Authors:  Carla M Yuede; Hongxin Dong; John G Csernansky
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

10.  Neural Protein Synthesis during Aging: Effects on Plasticity and Memory.

Authors:  Lesley A Schimanski; Carol A Barnes
Journal:  Front Aging Neurosci       Date:  2010-08-06       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.